3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Myelodysplastic Syndromes
41
Leukemia, Lymphocytic, Chronic, B-Cell
30
Lymphoma, Non-Hodgkin
27
Multiple Myeloma
22
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Hodgkin Disease
20
Leukemia
17
Myeloproliferative Disorders
16
Recurrence
15
Lymphoma, Follicular
15
Leukemia, Biphenotypic, Acute
15
Melanoma
14
Lymphoma, Mantle-Cell
14
Lymphoma
14
Leukemia, Myelomonocytic, Chronic
14
Lymphoma, Large B-Cell, Diffuse
13
Hematologic Neoplasms
13
Burkitt Lymphoma
11
Anemia, Refractory, with Excess of Blasts
11
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Primary Myelofibrosis
8
Neoplasm, Residual
7
Neoplasm Metastasis
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Neoplasms
6
Graft vs Host Disease
6
Interventions
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
3
pembrolizumab
2
cabozantinib
2
aldesleukin
2
Specimen Handling
2
CTLA-4 Antigen
2
Adoptive Transfer
2
niraparib
1
lenvatinib
1
entinostat
1
enfortumab vedotin
1
dostarlimab
1
cemiplimab
1
bintrafusp alfa protein, human
1
avelumab
1
Psychiatric Nursing
1
Platinum
1
Physical Therapy Modalities
1
Palliative Care
1
Paclitaxel
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Cisplatin
1
CP protocol
1
Biopsy
1
BAY 1895344
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Penile Neoplasms
×
fludarabine phosphate
×
1 year
×
Clear all
No trials found.